While the most widely accepted mode of action of enzalutamide is targeting AR activity, there is evidence that this drug also triggers apoptosis and attenuates the expression of anti-apoptotic proteins and heat shock proteins such as HSP27 in PCa cells and other cancer cell types [103,104,105,106]. This evidence concerns the gene AR and cancer.